Come up with a name for your new list and we'll add to it:
DiaKine Therapeutics raised a round of funding on , . Investors include
BlueTree Allied Angels.
DiaKine Therapeutics, Inc. is a development-stage company commercializing immune modulators such as Lisofylline (LSF) and related oral compounds into therapies for diabetes and related complications. …